Hand K-wire Infections in Operating Room Versus Ambulatory Setting
NCT ID: NCT02870465
Last Updated: 2022-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1042 participants
OBSERVATIONAL
2016-09-29
2021-09-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IM Screw vs. K-wire Fixation of Proximal/Middle Phalanx Fractures
NCT06372067
Cemented K-wire Fixation vs Open Transfixion Pinning
NCT03082872
Cemented K-wire Fixation vs Plating for Finger Fractures
NCT03031015
Buried Intramedullary K-wire Fixation Compared With Plate and Screw Fixation for Metacarpal Fractures in Unstable Extra-Articular Metacarpal Fractures
NCT02718170
Assessment of Fixation Strategies for Severe Open Tibia Fractures
NCT01494519
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will recruit patients prospectively from the emergency room or clinic referrals. All patients who meet the inclusion and exclusion criteria will be asked to participate by the attending surgeon or resident. The patients will be assigned a number according to chronological presentation. The patients will be recruited from academic centers in Canada. Three centers, Halifax, Toronto and McMaster, do not perform CRIF with K-wires in a clinical setting and thus will represent the main operating room cohort. The clinical setting CRIF cohort will be comprised of patients from St. John, Calgary, Ottawa, Vancouver and St John's where CRIF of hand fractures are routinely performed under local anaesthetic and field sterility. The characteristics of the injury, fracture, timing of injury, patient comorbidities which predispose to infections, handedness, smoking status, sex and age will be recorded.
All procedures in the operating room or the clinic area will be performed under the anaesthetic that is standard in that center. A procedure will be deemed "field sterility" if the usual surgical preparation of povidone-iodine or isopropyl alcohol-chlorohexidine gluconate and sterile drape is performed with sterile gloves and masks but without surgical gowns. In the outpatient clinic area, a basic tray will be used along with the K-wire driver and wire-cutters. A mini C-arm fluoroscopy machine is used to visualize the reduction and placement of the K-wires. The patients will then be dressed with a non-antibiotic containing dressing and splinted. The surgical information such as number and type of K-wires, OR time, type of anaesthesia, place of operation, and antibiotic use will be recorded. There will be no additional pin site care offered, as there is no standard accepted method to decrease pin-tract infection. They will be followed up as per the local protocol.
The patients will be instructed that if they are concerned regarding a complication or infection that they must present to their attending surgeon or other plastic surgery colleague covering outpatient calls. They will be provided a contact number for after hours. The necessity to contact the attending team will be stressed to improve documentation of complications and ensure that the proper diagnosis of an infection will be made and appropriate antibiotic coverage started. If the patient is to present to the emergency department or family physician, improper antibiotic coverage may be started for a patient presenting with normal wound healing, which will falsely elevate the incidence of recorded hand infections. The patient will be followed until K-wire removal around 3 to 4 weeks, as per local protocol, and the duration of K-wire fixation will be recorded along with any complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRIF in operating room
Patients who present with a hand fracture amendable to closed reduction internal fixation (CRIF) who are managed in the operating room.
Closed Reduction Internal Fixation
K-wires placed percutaneously through the skin to achieve fixation of a hand after reduction of the fracture in a closed manner.
CRIF outside of operating room
Patients who present with a hand fracture amendable to closed reduction internal fixation (CRIF) who are managed outside of the operating room (i.e.: in clinical setting, the emergency department or minor procedures area).
Closed Reduction Internal Fixation
K-wires placed percutaneously through the skin to achieve fixation of a hand after reduction of the fracture in a closed manner.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Closed Reduction Internal Fixation
K-wires placed percutaneously through the skin to achieve fixation of a hand after reduction of the fracture in a closed manner.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Multiple fractures or significant injury requiring ORIF by other means - such as plate fixation
3. Existing infection
4. Pathologic fracture
5. CRIF performed during replantation or revascularization of digit
6. Concomitant injury (tendon injury, nerve injury, soft tissue loss requiring reconstructive procedure such as graft or flap)
7. Other disease according to investigator's judgment
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Horizon Health Network
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Don Lalonde MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donald Lalonde, MD
Role: PRINCIPAL_INVESTIGATOR
Horizon Health Network
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univeristy of Calgary
Calgary, Alberta, Canada
Fraser Health
New Westminster, British Columbia, Canada
Lion's Gate Hospital
Vancouver, British Columbia, Canada
University of Manitoba
Winnipeg, Manitoba, Canada
Horizon Health Network
Saint John, New Brunswick, Canada
Memorial University
St. John's, Newfoundland and Labrador, Canada
St. Martha's Regional Hospital
Antigonish, Nova Scotia, Canada
Dalhousie University
Halifax, Nova Scotia, Canada
McMaster University
Hamilton, Ontario, Canada
Univeristy of Ottawa
Ottawa, Ontario, Canada
University of Toronto
Toronto, Ontario, Canada
McGill University
Montreal, Quebec, Canada
University of Montreal
Montreal, Quebec, Canada
Saint-Hyacinthe
Saint-Hyacinthe, Quebec, Canada
Philippine Orthopedic Center, Ma. Clara Corner Banawe Street
Quezon City, , Philippines
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HHN-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.